Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Genitourinary Cancers
How would you manage a patient who developed an intraprostatic abscess after SpaceOAR injection, prior to starting radiation?
Would you hold RT until resolution of infection?
Related Questions
What dose/fractionation would you recommend for a prostate patient who previously received 1 of 5 planned fractions SBRT in 2020?
How do you decide between internal versus external decompression of malignant obstruction of the ureter (MUO)?
How do you approach radiotherapy planning when there is no identifiable prostate tissue after HIFU or TURP?
What data support the use of continuing GnRH therapy "backbone" in metastatic castration resistant prostate cancer (mCRPC) receiving additional therapies?
Is REZUM (water vapor thermotherapy for BPH) safe after EBRT?
How do you talk to patients with intermediate-risk prostate cancer deciding between LDR brachytherapy (monotherapy) vs HDR mono vs SBRT vs EBRT, in terms of the comparative side effect profile of each approach?
How do you manage LUTS in the post-prostatectomy setting?
How long would you delay prostate radiation following use of a paclitaxel-eluting balloon dilator (optilume) for management of a recurrent urethral stricture after TURP?
Would you consider re-irradiation for a prostate local failure for a patient who initially received standard fractionation with a focal SIB to 95 Gy, or a SBRT boost with cyberknife after EBRT?
How do you manage significant gas in patients undergoing pelvic radiotherapy?